PRLB · Proto Labs Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | $295.99M | $277.69M | $281.88M | $272.93M | $265.41M | $216.57M |
| Gross Profit | $237.14M | $223.20M | $221.99M | $215.47M | $222.69M | $217.83M |
| R&D | $42.81M | $41.30M | $40.13M | $38.22M | $44.24M | $36.94M |
| SG&A | $69.81M | $64.33M | $65.79M | $67.54M | $55.93M | $51.74M |
| Total Operating Expenses | $212.03M | $203.29M | $193.83M | $313.45M | $182.35M | $157.99M |
| D&A | $33.81M | $35.81M | $37.53M | $39.42M | $40.49M | $32.59M |
| Operating Income | $25.11M | $19.91M | $28.17M | ($97.98M) | $40.34M | $59.84M |
| Interest Expense | - | - | - | - | - | - |
| Income Tax | $9.82M | $8.08M | $10.73M | $5.58M | $6.81M | $12.08M |
| Net Income | $21.24M | $16.59M | $17.22M | ($103.46M) | $33.37M | $50.87M |
| EPS - Basic | $0.89 | $0.66 | $0.66 | ($3.77) | $1.21 | $1.90 |
| EPS - Diluted | $0.88 | $0.66 | $0.66 | ($3.77) | $1.21 | $1.89 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $110.83M | $89.07M | $83.79M | $56.56M | $65.93M | $127.60M |
| Accounts Receivable | $78.96M | $66.50M | $72.85M | $76.22M | $80.05M | $57.88M |
| Inventory | $14.40M | $12.30M | $13.66M | $13.58M | $13.16M | $10.86M |
| Accounts Payable | $15.10M | $15.50M | $15.64M | $17.36M | $25.36M | $18.25M |
| Current Assets | $233.54M | $194.85M | $200.66M | $186.57M | $183.49M | $242.00M |
| Total Assets | $763.41M | $743.51M | $772.35M | $802.17M | $928.58M | $744.20M |
| Current Liabilities | $67.00M | $53.27M | $49.68M | $71.58M | $54.90M | $50.25M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $89.48M | $73.36M | $77.06M | $104.52M | $100.09M | $99.85M |
| Stockholders' Equity | $673.93M | $670.15M | $695.29M | $697.65M | $828.49M | $644.36M |
| Retained Earnings | $240.76M | $244.41M | $256.40M | $258.24M | $376.73M | $362.90M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $74.50M | $77.83M | $73.27M | $62.08M | $55.24M | $106.97M |
| Investing Cash Flow | ($13.41M) | ($13.58M) | ($4.55M) | ($43.09M) | ($94.66M) | ($95.47M) |
| Financing Cash Flow | ($40.37M) | ($58.55M) | ($41.86M) | ($27.92M) | ($22.20M) | ($10.73M) |
| CapEx | $14.84M | $9.17M | $28.12M | $21.69M | $34.21M | $47.01M |
| Free Cash Flow | $59.66M | $68.66M | $45.16M | $40.39M | $21.03M | $59.96M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | 2.81 | 4.14 | 2.62 | -0.39 | 0.63 | 1.18 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - |
| Effective tax rate | 31.6% | 32.7% | 38.4% | - | 17.0% | 19.2% |
| Return on assets | 2.8% | 2.2% | 2.2% | -12.9% | 3.6% | 6.8% |
| Return on equity | 3.2% | 2.5% | 2.5% | -14.8% | 4.0% | 7.9% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 3.49 | 3.66 | 4.04 | 2.61 | 3.34 | 4.82 |
| Quick ratio | 3.27 | 3.43 | 3.76 | 2.42 | 3.10 | 4.60 |
| Cash ratio | 1.65 | 1.67 | 1.69 | 0.79 | 1.20 | 2.54 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | 1.13 | 1.11 | 1.11 | 1.15 | 1.12 | 1.15 |
| Liabilities / Assets | 0.12 | 0.10 | 0.10 | 0.13 | 0.11 | 0.13 |
| Efficiency | ||||||
| Asset turnover | - | - | - | - | - | - |
| Inventory turnover | 20.55 | 22.57 | 20.64 | 20.10 | 20.17 | 19.94 |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | 18d | 16d | 18d | 18d | 18d | 18d |
| Days payable outstanding | 19d | 20d | 20d | 23d | 35d | 31d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 57.5x | 59.2x | 59.0x | - | 42.4x | 81.2x |
| P / B | 1.8x | 1.5x | 1.5x | 1.0x | 1.7x | 6.4x |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | 18.9x | 16.1x | 14.3x | - | 16.8x | 43.3x |
| Growth | ||||||
| Revenue growth (YoY) | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - |
| Gross profit growth (YoY) | 6.2% | 0.5% | 3.0% | -3.2% | 2.2% | -7.4% |
| Operating income growth (YoY) | 26.1% | -29.3% | - | - | -32.6% | -25.1% |
| Net income growth (YoY) | 28.0% | -3.6% | - | - | -34.4% | -20.1% |
| EPS growth (YoY) | 33.3% | 0.0% | - | - | -36.0% | -19.6% |
| EPS CAGR (3y) | - | -18.3% | -29.6% | - | -24.5% | -0.7% |
| EPS CAGR (5y) | -14.2% | -22.4% | -25.2% | - | -5.6% | 1.3% |
| FCF growth (YoY) | -13.1% | 52.0% | 11.8% | 92.0% | -64.9% | 11.4% |
| FCF CAGR (5y) | -0.1% | 5.0% | 4.7% | -2.1% | -12.6% | 33.4% |
| Book value growth (YoY) | 0.6% | -3.6% | -0.3% | -15.8% | 28.6% | 10.0% |
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- -Gross margin improved
- -Asset turnover improved
Peer comparison
Same SIC group: Fabricated Structural Metal Products
Comparing Proto Labs Inc against the 5 most active filers in the same SIC group.